KANTAR HEALTH BLOG

Pharma executives aiming to do business in Korea must take several key steps to ensure success in this prime growth market.

Taiwan is one of the top healthcare growth markets, successfully balancing rising healthcare costs and providing patients with access to affordable therapies. However, Taiwan faces several significant challenges including a lack of budget for innovative new medicines as well as barriers to patient accessibility.

Kantar Health's Global Health and Wellness Report remains the world's most comprehensive, patient-centric examination of global healthcare – providing unique insights on the most pressing health challenges facing the United States, the EU5, Japan, and the key healthcare growth markets of China, Brazil and Russia.

As the second most populous country in the world, India faces a wide variety of health challenges across its diverse demographics. For pharma companies to achieve commercial success, a local presence and a comprehensive understanding of the Indian market nuances are a must for developing and executing a highly informed market access strategy.

Brazil is bursting with opportunities for pharma companies- but only those who understand this growth market's nuances will succeed.